carbenoxolone sodium has been researched along with Liver Cirrhosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves de Castro, I; Barbisan, LF; Cogliati, B; Crespo Yanguas, S; da Silva, TC; Leclercq, I; Leybaert, L; Maes, M; Pereira, IVA; Romualdo, GR; Sayuri Nogueira, M; Vinken, M; Willebrords, J | 1 |
1 other study(ies) available for carbenoxolone sodium and Liver Cirrhosis
| Article | Year |
|---|---|
TAT-Gap19 and Carbenoxolone Alleviate Liver Fibrosis in Mice.
Topics: Animals; Anti-Inflammatory Agents; Carbenoxolone; Cells, Cultured; Connexin 43; Hepatic Stellate Cells; Liver Cirrhosis; Male; Mice; Mice, Inbred BALB C; Peptide Fragments; Superoxide Dismutase; Thioacetamide | 2018 |